Production (Stage)
E
Camp4 Therapeutics Corporation CAMP
$2.00 -$0.005-0.25% NASDAQ
Recommendation
Prev Close
$2.00
Volume
193,951
Avg Vol (90D)
197,938
Market Cap
$40.31M
Dividend & Yield
--
52-Week Range
$1.61 - $12.30
P/E (TTM)
--
EPS (TTM)
-$25.58
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Piper Sandler Keeps Their Buy Rating on CAMP4 Therapeutics Corporation (CAMP)
5/19/2025 - TipRanks Financial Blog
CAMP4 Therapeutics (CAMP) Highlights Promising Data from Gene Therapy Trials CAMP Stock News
5/16/2025 - GuruFocus
Camp4 Therapeutics delivers three presentantions on SYNGAP1-related disorders
5/16/2025 - TipRanks Financial Blog
Camp4 Therapeutics delivers three presentantions on SYNGAP1-related disorders
5/16/2025 - The Fly
CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting
5/16/2025 - Globe Newswire
Camp4 Therapeutics Corp Reports Q1 2025 Net Loss of $12.4 Million, Cash Reserves at $49.3 Million
5/15/2025 - GuruFocus
William Blair Sticks to Its Buy Rating for CAMP4 Therapeutics Corporation (CAMP)
5/14/2025 - TipRanks Financial Blog
Camp4 Therapeutics reports Q1 EPS (62c), consensus (70c)
5/13/2025 - The Fly
CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights
5/13/2025 - Globe Newswire
CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting
4/28/2025 - Globe Newswire
CAMP4 Therapeutics Advances RNA-Based Therapeutics
4/1/2025 - TipRanks Financial Blog
Camp4 Therapeutics Corp Reports 2024 Financial Results with $51. ...
3/29/2025 - GuruFocus
William Blair Sticks to Its Buy Rating for CAMP4 Therapeutics Corporation (CAMP)
3/28/2025 - TipRanks Financial Blog
CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update
3/27/2025 - Globe Newswire
Camp4 Therapeutics appoints Williams, Stewart to board of directors
3/18/2025 - The Fly
CAMP4 Appoints Multiple Industry Veterans to its Board of Directors
3/18/2025 - Globe Newswire
CAMP4 Therapeutics Corporation (CAMP): Among Penny Stocks with Insider Buying in 2025
3/4/2025 - Insider Monkey
12 Penny Stocks with Insider Buying in 2025
3/4/2025 - Insider Monkey
CAMP4 to Participate in Upcoming Investor Conferences
2/6/2025 - Globe Newswire
CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference
1/13/2025 - Globe Newswire
Camp4 Therapeutics sees MAD safety and key biomarker data in 2H25
1/7/2025 - The Fly
CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones
1/7/2025 - Globe Newswire
Analysts Forecast 26% Gains Ahead For VTWG
12/26/2024 - ETF Channel
Camp4 Therapeutics appoints Maraganore, Meyers are strategic advisors
12/10/2024 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
$62.77M
Total Debt (Q)
$7.96M
Total Liabilities (Q)
$11.20M
Book Value Per Share (Q)
$2.56
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Tuesday, May 13, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Oct 6 and 10 (est)
Price History
Loading...
Beta
--
7-Day Total Return
-4.76%
30-Day Total Return
0.00%
60-Day Total Return
-59.27%
90-Day Total Return
-54.65%
Year to Date Total Return
-59.43%
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Apr 17, 2025 - $1.61
52-week High
Oct 14, 2024 - $12.30
Valuation
Market Cap
$40.31M - Nano Cap
Enterprise Value
-$1.05M
Price/Sales (TTM)
26.70
Price/Book (Q)
0.78
Dividends and Shares
Shares Outstanding
20.15M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.camp4tx.com
Phone Number
617-651-8867
Address
One Kendall Square
3rd Floor - Building 1400 West
Cambridge, MA 02139
Country
United States
Year Founded
2015
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product... more
NASDAQ 05/23/2025 4:00PM Eastern Quotes delayed